Latest media releases
UBS launches a fund with 130/30 strategy: UBS Key Selection US Equities 130/30
Private investors gain access to novel investment concept
UBS is offering a new fund based on an investment concept incorporating a 130/30 strategy: UBS (Lux) Key Selection Sicav - US Equities 130/30 B.
Up to now, fund products with a 130/30 strategy have mostly been the preserve of institutional investors. With this new fund private investors can gain access to this strategy as well. It differs from other equity funds, which only invest in long positions, by taking advantage of additional sources of outperformance through a 130/30 strategy that entails 130% long positions and 30% short positions on average.
A long-only portfolio is invested in stocks which the portfolio manager sees as undervalued and avoids those which are thought to be overvalued. Relaxing this restriction allows UBS Key Selection US Equities 130/30 to generate returns from overvalued stocks, too, by taking up short positions. Thanks to this flexibility, the fund has more potential to outperform than long-only equity funds. Moreover, its risk level (i.e. volatility) is not substantially higher than the market average.
The UBS Key Selection US Equities 130/30 portfolio is broadly diversified in terms of both stocks and sectors and favours listed US large and mid caps. Its benchmark is the internationally-recognized MSCI USA (r).
The new fund presents investors with an attractive opportunity to gain exposure to the US equity market. It is suitable for private investors with a long-term investment horizon.
UBS (Lux) Key Selection Sicav 2 - US Equities 130/30 B
3100073 / LU0300928990
UBS Global Asset Management (Americas) Inc., Chicago
UBS (Lux) Key Selection Sicav 2
MSCI USA (r)
27 June 2007
Currency of account
Accounting year ends
Withholding tax/tax at source
Products and services in these webpages may not be available for residents of certain nations. Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2013. All rights reserved.